BON Announces Identification of Promising Weight-Managing Compounds from Tea via AI-Powered New Drug R&D Platform
1. BON identifies natural compounds that outperform current weight-management drugs. 2. The global weight management market is projected to grow to $601.26 billion by 2029. 3. BON's AI platform streamlines drug research, enhancing efficiency in development. 4. Preliminary studies show significant weight reduction with no adverse effects. 5. Successful launch could increase BON's market share and enhance shareholder returns.